The restructuring eliminates expensive EIB debt and residual warrant overhang but creates moderate near-term dilution via convertibles. Monitor the June 30 shareholder vote on new EIB warrants and NATiV3 trial readout (Tranche C trigger). The minimum cash covenant (€30M floor) and market-cap testing mechanism provide early warning on financial health — below €2B market cap for 7 days could limit financial flexibility. The overall capital structure clean-up with BlackRock/Claret is credit-positive but the dilution and trial-dependency warrant a cautious stance.
Price Chart
Executive Summary
Inventiva closed a multi-step capital restructuring on June 12, 2026: repaying €62.2M in EIB loans, repurchasing ~2.97M EIB warrants for €50M, and issuing €75M in convertible/amortized bonds with BlackRock/Claret (net €71.3M). An amendment to the subscription agreement formalizes a market-cap-based minimum cash covenant test (€30M floor, disapplied above €2B market cap). This replaces expensive/onerous EIB debt with BlackRock/Claret financing but adds future dilution via convertible bonds and warrants.
Key Facts
- Repaid €62,204,436 in EIB loans (including accrued interest, EIB waived early prepayment fees)
- Repurchased and cancelled all 2,266,023 EIB Tranche A Warrants and 700,000 Tranche B Warrants for €50M (eliminating ~22.7M shares of potential dilution from those warrants)
- Issued €35M Tranche A Convertible Bonds (conversion price €5.2893, 40% premium to equity offering price) and €40M Tranche B Amortized Bonds, net proceeds €71,298,750
- Issued 1,624,196 Tranche A/B Lenders' Warrants (exercise price €4.1559, 10% premium) and 661,709 Tranche C Lenders' Warrants
- Remaining EIB Tranche B Warrants (~2.44M) to be surrendered for new EIB warrants subject to shareholder vote on June 30, 2026
- Minimum cash covenant set at €30M, with structured monthly testing; covenant disapplies if market cap exceeds €2B for 15 consecutive days, reapplies below €2B for 7 days
- Convertible bonds convert into ~6.6M new ordinary shares at current conversion price; warrants represent ~2.3M additional shares if fully exercised
- Tranche C Amortized Bonds (up to €55M) contingent on NATiV3 trial success and further equity raise
- Annual general meeting scheduled for June 30, 2026
Financial Impact
Total proceeds from equity offering ($120M) + debt issuance (€75M gross / €71.3M net) less €62.2M debt repayment and €50M warrant repurchase creates net cash inflow of roughly €50-60M after all transactions. Dilution: ~27.3M ADS from equity offering (settled June 5), plus up to ~8.9M shares from convertible bonds + warrants combined, representing ~30-40% potential dilution vs pre-offering share count.
Risk Factors
- NATiV3 trial failure would block Tranche C Amortized Bonds (€55M potential), requiring additional capital
- Potential dilution from conversion/exercise of ~8.9M shares if convertibles and warrants are exercised
- Remaining EIB warrant replacement subject to shareholder approval — failure could leave residual warrant overhang
- Minimum cash covenant of €30M could restrict cash usage if market cap dips below €2B
- Company still pre-revenue with significant operating losses; cash runway depends on trial milestones
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-073545 |
| Document: tm2617723d2_ex99-1.htm | 0001104659-26-073545 |
| Document: tm2617723d2_6k.htm | 0001104659-26-073545 |
| Document: 0001104659-26-073545-index-headers.html | 0001104659-26-073545 |
| Document: 0001104659-26-073545-index.html | 0001104659-26-073545 |
| Document: 0001104659-26-073545.txt | 0001104659-26-073545 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 21d ago | 6-K | $3.37 | awaiting T+20 | — | $3.68 (+9.51%) |
Sep 28, 2026 29d ago | 6-K | $3.53 $3.66 | ▲ +3.68% | ▲ +3.71% | $3.68 (+4.39%) |
Sep 3, 2026 7w ago | 6-K | $4.84 $3.56 | ▼ −26.45% | ▼ −25.26% | $3.68 (−23.86%) |
Jul 6, 2026 16w ago | 6-K | $3.90 $4.48 | ▲ +14.87% | ▲ +15.44% | $3.68 (−5.51%) |
Jun 12, 2026 19w ago | 6-K | $3.76 $4.30 | ▲ +14.36% | ▲ +15.11% | $3.68 (−1.99%) |
Jun 12, 2026 19w ago | 6-K | $3.85 $4.30 | ▲ +11.69% | ▲ +9.91% | $3.68 (−4.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers